EPISODE · Nov 7, 2022 · 1H
Episode 37
from Biotech Hangout · host Daphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler and more
In this episode, Daphne, Bruce, Tim and guest Jefferies’ Michael Yee discuss the latest happenings in biotech, including recent key earnings, clinical data including ASH abstracts, “BAMG (Bristol Myers Squibb, Amgen, Merck and Gilead) as the new FAANG” and ways that companies are navigating the current challenging financing environment including debt, royalties, reverse mergers & the idea of returning capital after a setback. The episode also delves into the healthy follow-on financing environment.
NOW PLAYING
Episode 37
No transcript for this episode yet
Similar Episodes
May 12, 2026 ·36m
May 12, 2026 ·37m
May 11, 2026 ·11m
May 11, 2026 ·34m
May 11, 2026 ·38m